1. Home
  2. DGII vs NVAX Comparison

DGII vs NVAX Comparison

Compare DGII & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digi International Inc.

DGII

Digi International Inc.

HOLD

Current Price

$47.23

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.49

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGII
NVAX
Founded
1985
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
DGII
NVAX
Price
$47.23
$8.49
Analyst Decision
Strong Buy
Hold
Analyst Count
5
9
Target Price
$48.80
$11.33
AVG Volume (30 Days)
228.0K
3.7M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
77.05
309.76
EPS
0.31
2.58
Revenue
$430,221,000.00
$1,123,479,000.00
Revenue This Year
$18.71
N/A
Revenue Next Year
$7.22
N/A
P/E Ratio
$153.15
$3.28
Revenue Growth
1.46
64.69
52 Week Low
$22.39
$5.01
52 Week High
$51.78
$11.85

Technical Indicators

Market Signals
Indicator
DGII
NVAX
Relative Strength Index (RSI) 44.03 38.12
Support Level $42.69 $8.01
Resistance Level $47.86 $9.05
Average True Range (ATR) 1.71 0.54
MACD -0.35 -0.23
Stochastic Oscillator 5.53 1.81

Price Performance

Historical Comparison
DGII
NVAX

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: